Clinical Trial Update: Treatment of Polycythemia Vera With Gleevec [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating imatinib (Gleevec) for polycythemia vera has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Polycythemia Vera | Phase 2 | Status: COMPLETED